Phase 4 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose HbA1c blood sugar level falls between 5.7 and 6.4 (a range sometimes called "prediabetes")
- People whose body mass index (a measure of body weight relative to height) falls between 27 and 45
Who may not be able to join:
- People who have diabetes
- People who regularly take any medications used to lower blood sugar
- People who have any unstable medical condition
- People who use steroid medications, or who take anti-inflammatory pain relievers (such as ibuprofen) on a daily basis
- People who have a history of long-term inflammatory conditions
- People who take blood-thinning medications
- People for whom the trial medications (mirabegron or tadalafil) would not be considered safe to use (confirm with trial site)
- People whose doctor running the study considers them to be at too high a risk to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Philip Kern, M.D., University of Kentucky
Phone: 859-218-1397
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Oral glucose tolerance test; Oral glucose tolerance test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.